Pregnancy and medicines: time for paradigm change.
作者信息
Saint-Raymond Agnes, Mofenson Lynne M
机构信息
Paris, France.
Research Department, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
出版信息
J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25906. doi: 10.1002/jia2.25906.
Abstract
摘要
相似文献
1
Pregnancy and medicines: time for paradigm change.妊娠与药物：范式转变之时。
J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25906. doi: 10.1002/jia2.25906.
2
Reporting of offspring data in diabetes, HIV infection and hypertension trials during pregnancy: a systematic review.妊娠期糖尿病、HIV 感染和高血压试验中后代数据的报告：系统评价。
Arch Dis Child Fetal Neonatal Ed. 2020 Mar;105(2):215-221. doi: 10.1136/archdischild-2019-316982. Epub 2019 Oct 9.
3
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action.加速妊娠中新 HIV 药物的研究：将研究议程从理论推进到实践。
J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25912. doi: 10.1002/jia2.25912.
4
Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus.患有人类免疫缺陷病毒的孕妇和哺乳期妇女进行前瞻性研究的重要性。
Clin Infect Dis. 2019 Sep 13;69(7):1254-1258. doi: 10.1093/cid/ciz121.
5
Mefloquine for preventing malaria in pregnant women.甲氟喹预防孕妇疟疾
Cochrane Database Syst Rev. 2018 Mar 21;3(3):CD011444. doi: 10.1002/14651858.CD011444.pub2.
6
Contraception and pregnancy in microbicide trials.杀微生物剂试验中的避孕与妊娠。
Best Pract Res Clin Obstet Gynaecol. 2012 Aug;26(4):473-86. doi: 10.1016/j.bpobgyn.2012.01.005. Epub 2012 Mar 3.
7
Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.中-英医学学术文献翻译：来自加蓬和莫桑比克的 HIV 感染孕妇间断性预防治疗应用双氢青蒿素哌喹的安全性和有效性：一项随机、双盲、安慰剂对照试验。
Lancet Infect Dis. 2024 May;24(5):476-487. doi: 10.1016/S1473-3099(23)00738-7. Epub 2024 Jan 12.
8
Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies.孕期暴露于洛匹那韦，但不是达鲁那韦，会损害蜕膜化：这是导致 HIV 阳性孕妇不良妊娠结局的潜在机制。
Hum Reprod. 2020 Aug 1;35(8):1781-1796. doi: 10.1093/humrep/deaa151.
9
Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?将孕妇纳入抗逆转录病毒药物研究：需要做些什么才能向前推进？
J Int AIDS Soc. 2019 Sep;22(9):e25372. doi: 10.1002/jia2.25372.
10
Traditional medicines, HIV, and related infections: workshop 2C.传统医学、艾滋病病毒及相关感染：研讨会2C
Adv Dent Res. 2011 Apr;23(1):159-64. doi: 10.1177/0022034511400077.
引用本文的文献
1
Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in Africa.孕期使用抗逆转录病毒药物预防艾滋病毒：非洲加强监管和监测系统的必要性。
Drug Saf. 2025 Mar;48(3):209-216. doi: 10.1007/s40264-024-01494-6. Epub 2025 Jan 26.
2
Knowledge, attitude, and practice of medication use among pregnant women in Riyadh City: a cross-sectional study.利雅得市孕妇用药的知识、态度及行为：一项横断面研究
Front Glob Womens Health. 2024 Jul 24;5:1402608. doi: 10.3389/fgwh.2024.1402608. eCollection 2024.
3
Disrupting the status quo to achieve early inclusion of pregnant women in studies of new agents for prevention and treatment of HIV infection.打破现状，以尽早将孕妇纳入预防和治疗艾滋病毒感染新药物的研究。
J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25927. doi: 10.1002/jia2.25927.
本文引用的文献
1
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action.加速妊娠中新 HIV 药物的研究：将研究议程从理论推进到实践。
J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25912. doi: 10.1002/jia2.25912.
2
Ending the evidence gap for pregnancy, HIV and co-infections: ethics guidance from the PHASES project.消除妊娠、艾滋病毒及合并感染方面的证据差距：来自PHASES项目的伦理指南
J Int AIDS Soc. 2021 Dec;24(12):e25846. doi: 10.1002/jia2.25846.
3
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.会议报告：CEPI 关于加速为孕妇和哺乳期妇女提供新型传染病疫苗的咨询会，2020 年 2 月 12-13 日，伦敦。
Vaccine. 2021 Dec 17;39(51):7357-7362. doi: 10.1016/j.vaccine.2021.10.048. Epub 2021 Nov 17.
4
Prescription medications for use in pregnancy-perspective from the US Food and Drug Administration.妊娠期处方药物使用——来自美国食品药品监督管理局的视角。
Am J Obstet Gynecol. 2021 Jul;225(1):21-32. doi: 10.1016/j.ajog.2021.02.032.
5
Assuring Access to Safe Medicines in Pregnancy and Breastfeeding.保障妊娠和哺乳期安全用药。
Clin Pharmacol Ther. 2021 Oct;110(4):941-945. doi: 10.1002/cpt.2212. Epub 2021 May 1.
6
Enhanced and Timely Investigation of ARVs for Use in Pregnant Women.加强并及时调查抗逆转录病毒药物在孕妇中的应用。
J Acquir Immune Defic Syndr. 2021 Apr 15;86(5):607-615. doi: 10.1097/QAI.0000000000002597.
7
Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement.优化孕妇和哺乳期妇女的药理学研究：从 HIV 中吸取的经验教训：共识声明。
Clin Pharmacol Ther. 2021 Jul;110(1):36-48. doi: 10.1002/cpt.2048. Epub 2020 Oct 15.
8
Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?将孕妇纳入抗逆转录病毒药物研究：需要做些什么才能向前推进？
J Int AIDS Soc. 2019 Sep;22(9):e25372. doi: 10.1002/jia2.25372.
9
Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus.患有人类免疫缺陷病毒的孕妇和哺乳期妇女进行前瞻性研究的重要性。
Clin Infect Dis. 2019 Sep 13;69(7):1254-1258. doi: 10.1093/cid/ciz121.
Zotero 插件